4//SEC Filing
Lu Hongbo 4
Accession 0001628280-24-012327
CIK 0000879407other
Filed
Mar 19, 8:00 PM ET
Accepted
Mar 20, 7:06 PM ET
Size
8.0 KB
Accession
0001628280-24-012327
Insider Transaction Report
Form 4
Lu Hongbo
Director
Transactions
- Purchase
Common Stock
2024-03-18$27.49/sh+1,000$27,490→ 31,680 total - Purchase
Common Stock
2024-03-19$28.00/sh+1,000$28,000→ 32,680 total - Purchase
Common Stock
2024-03-20$27.50/sh+1,000$27,500→ 33,680 total
Footnotes (1)
- [F1]The price reported on Column 4 is the weighted average price. These shares were purchase in multiple transactions at prices ranging from $ 27.48 to $ 27.50, inclusive. The reporting person undertakes to provide to Arrowhead Pharmaceuticals, Inc., any security holder of Arrowhead Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote of this Form 4.
Documents
Issuer
ARROWHEAD PHARMACEUTICALS, INC.
CIK 0000879407
Entity typeother
Related Parties
1- filerCIK 0001767584
Filing Metadata
- Form type
- 4
- Filed
- Mar 19, 8:00 PM ET
- Accepted
- Mar 20, 7:06 PM ET
- Size
- 8.0 KB